DNA topoisomerase II in therapy-related acute promyelocytic leukemia. Mistry AR, Felix CA, Whitmarsh RJ, Mason A, Reiter A, Cassinat B, Parry A, Walz C, Wiemels JL, Segal MR, Adès L, Blair IA, Osheroff N, Peniket AJ, Lafage-Pochitaloff M, Cross NC, Chomienne C, Solomon E, Fenaux P, Grimwade D (2005) N Engl J Med 352: 1529-38 Second neoplasms in survivors of childhood cancer: findings from the Childhood Cancer Survivor Study cohort. Meadows AT, Friedman DL, Neglia JP, Mertens AC, Donaldson SS, Stovall M, Hammond S, Yasui Y, Inskip PD (2009) J Clin Oncol 27: 2356-62 Dexrazoxane-associated risk for acute myeloid leukemia/myelodysplastic syndrome and other secondary malignancies in pediatric Hodgkin's disease. Tebbi CK, London WB, Friedman D, Villaluna D, De Alarcon PA, Constine LS, Mendenhall NP, Sposto R, Chauvenet A, Schwartz CL (2007) J Clin Oncol 25: 493-500 Risk of selected subsequent carcinomas in survivors of childhood cancer: a report from the Childhood Cancer Survivor Study. Bassal M, Mertens AC, Taylor L, Neglia JP, Greffe BS, Hammond S, Ronckers CM, Friedman DL, Stovall M, Yasui YY, Robison LL, Meadows AT, Kadan-Lottick NS (2006) J Clin Oncol 24: 476-83 TP53, BRCA1, and BRCA2 tumor suppressor genes are not commonly mutated in survivors of Hodgkin's disease with second primary neoplasms. Nichols KE, Heath JA, Friedman D, Biegel JA, Ganguly A, Mauch P, Diller L (2003) J Clin Oncol 21: 4505-9 Pathologic features of initial adenomas as predictors for metachronous adenomas of the rectum. Yang G, Zheng W, Sun QR, Shu XO, Li WD, Yu H, Shen GF, Shen YZ, Potter JD, Zheng S (1998) J Natl Cancer Inst 90: 1661-5 Subsequent neoplasms in 5-year survivors of childhood cancer: the Childhood Cancer Survivor Study. Friedman DL, Whitton J, Leisenring W, Mertens AC, Hammond S, Stovall M, Donaldson SS, Meadows AT, Robison LL, Neglia JP (2010) J Natl Cancer Inst 102: 1083-95 Secondary sarcomas in childhood cancer survivors: a report from the Childhood Cancer Survivor Study. Henderson TO, Whitton J, Stovall M, Mertens AC, Mitby P, Friedman D, Strong LC, Hammond S, Neglia JP, Meadows AT, Robison L, Diller L (2007) J Natl Cancer Inst 99: 300-8 Second malignant neoplasms in five-year survivors of childhood cancer: childhood cancer survivor study. Neglia JP, Friedman DL, Yasui Y, Mertens AC, Hammond S, Stovall M, Donaldson SS, Meadows AT, Robison LL (2001) J Natl Cancer Inst 93: 618-29 Breast cancer after childhood cancer: a report from the Childhood Cancer Survivor Study. Kenney LB, Yasui Y, Inskip PD, Hammond S, Neglia JP, Mertens AC, Meadows AT, Friedman D, Robison LL, Diller L (2004) Ann Intern Med 141: 590-7 Near-precise interchromosomal recombination and functional DNA topoisomerase II cleavage sites at MLL and AF-4 genomic breakpoints in treatment-related acute lymphoblastic leukemia with t(4;11) translocation. Lovett BD, Lo Nigro L, Rappaport EF, Blair IA, Osheroff N, Zheng N, Megonigal MD, Williams WR, Nowell PC, Felix CA (2001) Proc Natl Acad Sci U S A 98: 9802-7 Genome-wide association study to identify novel loci associated with therapy-related myeloid leukemia susceptibility. Knight JA, Skol AD, Shinde A, Hastings D, Walgren RA, Shao J, Tennant TR, Banerjee M, Allan JM, Le Beau MM, Larson RA, Graubert TA, Cox NJ, Onel K (2009) Blood 113: 5575-82 Solid cancers after allogeneic hematopoietic cell transplantation. Rizzo JD, Curtis RE, Socié G, Sobocinski KA, Gilbert E, Landgren O, Travis LB, Travis WD, Flowers ME, Friedman DL, Horowitz MM, Wingard JR, Deeg HJ (2009) Blood 113: 1175-83 Secondary malignant neoplasms after Wilms tumor: an international collaborative study. Breslow NE, Lange JM, Friedman DL, Green DM, Hawkins MM, Murphy MF, Neglia JP, Olsen JH, Peterson SM, Stiller CA, Robison LL (2010) Int J Cancer 127: 657-66 Second solid malignancies among children, adolescents, and young adults diagnosed with malignant bone tumors after 1976: follow-up of a Children's Oncology Group cohort. Goldsby R, Burke C, Nagarajan R, Zhou T, Chen Z, Marina N, Friedman D, Neglia J, Chuba P, Bhatia S (2008) Cancer 113: 2597-604 Late effects of treatment for Hodgkin lymphoma. Friedman DL, Constine LS (2006) J Natl Compr Canc Netw 4: 249-57 A methodological issue in the analysis of second-primary cancer incidence in long-term survivors of childhood cancers. Yasui Y, Liu Y, Neglia JP, Friedman DL, Bhatia S, Meadows AT, Diller LR, Mertens AC, Whitton J, Robison LL (2003) Am J Epidemiol 158: 1108-13 Polymorphic variation in the GC and CASR genes and associations with vitamin D metabolite concentration and metachronous colorectal neoplasia. Hibler EA, Hu C, Jurutka PW, Martinez ME, Jacobs ET (2012) Cancer Epidemiol Biomarkers Prev 21: 368-75 Topoisomerase II and leukemia. Pendleton M, Lindsey RH, Felix CA, Grimwade D, Osheroff N (2014) Ann N Y Acad Sci 1310: 98-110 Incidence of additional primary malignancies in patients with pancreatic and gastrointestinal neuroendocrine tumors. Kauffmann RM, Wang L, Phillips S, Idrees K, Merchant NB, Parikh AA (2014) Ann Surg Oncol 21: 3422-8 Risk of subsequent malignancies in survivors of childhood leukemia. Perkins SM, Dewees T, Shinohara ET, Reddy MM, Frangoul H (2013) J Cancer Surviv 7: 544-50 Second malignancies after autologous hematopoietic cell transplantation in children. Danner-Koptik KE, Majhail NS, Brazauskas R, Wang Z, Buchbinder D, Cahn JY, Dilley KJ, Frangoul HA, Gross TG, Hale GA, Hayashi RJ, Hijiya N, Kamble RT, Lazarus HM, Marks DI, Reddy V, Savani BN, Warwick AB, Wingard JR, Wood WA, Sorror ML, Jacobsohn DA (2013) Bone Marrow Transplant 48: 363-8 Invited commentary. Deppen SA, Grogan EL (2012) Ann Thorac Surg 93: 1068-9 Surgical resection of non-small cell carcinoma after treatment for small cell carcinoma. Smythe WR, Estrera AL, Swisher SG, Merriman KW, Walsh GL, Putnam JB, Vaporciyan AA, Roth JA (2001) Ann Thorac Surg 71: 962-6 The risk of second primary tumors after resection of stage I nonsmall cell lung cancer. Rice D, Kim HW, Sabichi A, Lippman S, Lee JJ, Williams B, Vaporciyan A, Smythe WR, Swisher S, Walsh G, Putnam JB, Hong WK, Roth J (2003) Ann Thorac Surg 76: 1001-7; discussion 1007-8 Combined chest wall resection with vertebrectomy and spinal reconstruction for the treatment of Pancoast tumors. York JE, Walsh GL, Lang FF, Putnam JB, McCutcheon IE, Swisher SG, Komaki R, Gokaslan ZL (1999) J Neurosurg 91: 74-80 Risk factors for urothelial carcinoma of the prostate in patients undergoing radical cystoprostatectomy for bladder cancer. Patel SG, Cookson MS, Barocas DA, Clark PE, Smith JA, Chang SS (2009) BJU Int 104: 934-7 Classifying "recurrent" breast cancer: lost heterozygosity found. Hameed O, Pfeifer JD (2005) Am J Clin Pathol 123: 641-3 Osteosarcoma oncogene expression detected by in situ hybridization. Wang H, Rodgers WH, Chmell MJ, Svitek C, Schwartz HS (1995) J Orthop Res 13: 671-8 Risk of second primary thyroid cancer after radiotherapy for a childhood cancer in a large cohort study: an update from the childhood cancer survivor study. Bhatti P, Veiga LH, Ronckers CM, Sigurdson AJ, Stovall M, Smith SA, Weathers R, Leisenring W, Mertens AC, Hammond S, Friedman DL, Neglia JP, Meadows AT, Donaldson SS, Sklar CA, Robison LL, Inskip PD (2010) Radiat Res 174: 741-52 Basal cell skin cancer after total-body irradiation and hematopoietic cell transplantation. Schwartz JL, Kopecky KJ, Mathes RW, Leisenring WM, Friedman DL, Deeg HJ (2009) Radiat Res 171: 155-63 Metastatic Merkel cell carcinoma in the bone marrow of a patient with plasma cell myeloma and therapy-related myelodysplastic syndrome. Kressin MK, Kim AS (2012) Int J Clin Exp Pathol 5: 1007-12 Second malignant neoplasms following hematopoietic stem cell transplantation. Friedman DL, Leisenring W, Schwartz JL, Deeg HJ (2004) Int J Hematol 79: 229-34 Development of hepatic angiomyolipoma accompanied with focal nodular hyperplasia long after treatment of pelvic rhabdomyosarcoma. Honda M, Lee KJ, Hashimoto S, Hayashida S, Suda H, Ohya Y, Yamamoto H, Takeichi T, Asonuma K, Inomata Y (2011) J Pediatr Surg 46: 1267-70
Hints: (1) double-click or double-tap to navigate to a node. (2) Grab a node and move it to arrange the graph.